BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10174422)

  • 1. Legislative challenges facing managed care pharmacy.
    Epstein L
    Manag Care Interface; 1997 Oct; 10(10):92-4, 98. PubMed ID: 10174422
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory and legislative challenges facing managed care.
    Giaquinta D
    Manag Care Interface; 2000 Jul; 13(7):47-9. PubMed ID: 11183928
    [No Abstract]   [Full Text] [Related]  

  • 3. PBMs and a Medicare prescription drug benefit.
    Cohen JP
    Food Drug Law J; 2000; 55(3):311-20. PubMed ID: 11824463
    [No Abstract]   [Full Text] [Related]  

  • 4. Managed care pharmacy 101: learning from the students.
    Penna P
    Manag Care Interface; 2005 Apr; 18(4):28, 31. PubMed ID: 15889760
    [No Abstract]   [Full Text] [Related]  

  • 5. Effective strategies for managing pharmacy benefits.
    Jacobson D
    Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response to health care reform by the pharmaceutical industry.
    Krulwich AS
    Food Drug Law J; 1995; 50(1):1-22. PubMed ID: 10342983
    [No Abstract]   [Full Text] [Related]  

  • 7. Cut pharmaceutical costs, but mind the legal dangers.
    Abood RR
    Manag Care; 1997 Aug; 6(8):47-8, 51-4. PubMed ID: 10170246
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacy benefit management as a quality safeguard.
    Giaquinta D
    Manag Care Interface; 2002 Mar; 15(3):54, 57. PubMed ID: 11925680
    [No Abstract]   [Full Text] [Related]  

  • 9. Injectable drugs: the new frontier in pharmacy management.
    Rodgers JR
    Am J Manag Care; 2003 Jun; Suppl Decision Maker News():5-8. PubMed ID: 12866365
    [No Abstract]   [Full Text] [Related]  

  • 10. Access to pharmaceuticals under Medicaid managed care: federal law compiled and state contracts compared.
    Loza EL
    Food Drug Law J; 2000; 55(3):449-76. PubMed ID: 11824469
    [No Abstract]   [Full Text] [Related]  

  • 11. The FDA's regulation of pharmaceutical communications in the context of managed care: a suggested approach.
    Kuhlik BN
    Food Drug Law J; 1995; 50(1):23-48. PubMed ID: 10342984
    [No Abstract]   [Full Text] [Related]  

  • 12. Facing the next challenge of pharmaceutical care: patient noncompliance.
    Bloom DL
    Med Interface; 1996 Nov; 9(11):67-72. PubMed ID: 10162562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage decision-making in Medicaid managed care: key issues in developing managed care contracts.
    Rosenbaum S; Teitelbaum JB
    Issue Brief George Wash Univ Cent Health Serv Res Policy; 1998 May; (1):1-11. PubMed ID: 12425331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the Medicare modernization act for the treatment of osteoporosis.
    Stefanacci R
    Manag Care; 2005 Aug; 14(8 Suppl Osteoporosis):13-7; discussion 21-3. PubMed ID: 18564557
    [No Abstract]   [Full Text] [Related]  

  • 15. Managed care. Legislative overkill? Media begin to question push for more mandates.
    Kertesz L
    Mod Healthc; 1997 Apr; 27(15):76, 78. PubMed ID: 10166309
    [No Abstract]   [Full Text] [Related]  

  • 16. The changing temperament and retuning of practice for pharmacists.
    Vogenberg FR
    Hosp Pharm; 1995 Oct; 30(10):902, 904-6. PubMed ID: 10151953
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncharted waters: managed care and long-term care provider contracts.
    Harkins MJ; McMillen J
    J Health Hosp Law; 1997; 30(3):179-94. PubMed ID: 10179114
    [No Abstract]   [Full Text] [Related]  

  • 19. Perspectives. Will we try to manage care again? This time, for drugs?
    Clemmitt M
    Med Health; 2000 Jun; 54(25):suppl 1-4. PubMed ID: 11009923
    [No Abstract]   [Full Text] [Related]  

  • 20. Liability relating to formularies and drug utilization management.
    Elden DL
    AAPPO J; 1991; 1(2):33-7, 43-6. PubMed ID: 10148900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.